NCT06836206 (GAESRD) is a Phase 1, PHASE2 clinical trial of Gum Arabic in End Stage Renal Disease (ESRD), sponsored by Abu Dhabi Health Services Company.

Who is sponsoring NCT06836206?

NCT06836206 is sponsored by Abu Dhabi Health Services Company.

What drugs are being tested in NCT06836206?

Interventions in NCT06836206: Gum Arabic, Water.

What condition does NCT06836206 study?

NCT06836206 studies End Stage Renal Disease (ESRD).

Is NCT06836206 still recruiting?

NCT06836206 is currently recruiting now. Last updated 20 February 2025.

Last reviewed 2025-02-20 · How we verify

NCT06836206: GAESRD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi

Recruiting now Phase 1, PHASE2 Last updated 20 February 2025

What this trial tests

Phase 1, PHASE2 trial testing Gum Arabic in End Stage Renal Disease (ESRD) in 40 participants. Currently enrolling.

Timeline

3 February 2025

Primary endpoint
30 November 2025

30 April 2026

Quick facts

Lead sponsor	Abu Dhabi Health Services Company
Phase	Phase 1, PHASE2
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	3 February 2025
Primary completion	30 November 2025
Estimated completion	30 April 2026
Sites	1 location across United Arab Emirates

Drugs / interventions tested

Gum Arabic — full drug profile →
Water (WATER) — full drug profile →

Conditions studied

End Stage Renal Disease (ESRD) — all drugs for End Stage Renal Disease (ESRD) →

Sponsor

Abu Dhabi Health Services Company

Who can join

18 and older, any sex, with End Stage Renal Disease (ESRD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gum Arabic (GA), derived from Acacia trees, has shown potential benefits in metabolic, renal, and inflammatory conditions. This study explores the impact of GA on residual renal function in end-stage renal disease (ESRD) patients undergoing dialysis, as current evidence is limited.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Gum Arabic

Trials testing the same drug.

NCT04978103 — Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women · Phase 2 · completed
NCT03789708 — Effects of Gum Arabic Supplementation in Hemodialysis Patients · NA · unknown

Other recruiting trials for End Stage Renal Disease (ESRD)

Currently open trials in the same condition.

NCT07157397 — Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients · NA · recruiting
NCT07291154 — Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy · NA · recruiting
NCT06712251 — Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular A · NA · active not recruiting
NCT06597201 — Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Ma · Phase 4 · recruiting
NCT04671771 — A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients · NA · recruiting

Other Abu Dhabi Health Services Company trials

Trials by the same sponsor.

NCT06605677 — Knowledge Attitude and Practice Regarding Bloodstream Bacterial Infections and Antibiotics Usage Among Doctors. · enrolling by invitation
NCT06535542 — Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis · NA · recruiting
NCT06535503 — Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City · recruiting
NCT06531616 — Healthcare Professionals' Attitude Towards Clinical Research in the United Arab Emirates · completed
NCT06694961 — Knowledge of Adolescent Well-care Visits and Attitudes Amongst Physicians · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06836206 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abu Dhabi Health Services Company
Last refreshed: 20 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06836206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing